Management
Mark Busgang
President, Chief Executive Officer and Director
Mr. Busgang has been President and Chief Executive Officer of Warnex since February 1998. From 1993 to 1996, he was President of Pharmetics Ltd. During this period, he also co-founded Theratechnologies Inc. and served as Vice President of Operations. Mr. Busgang is presently Director of Laval Technopole, a member of the World Presidents' Organization and actively involved in many community and charitable organizations.
François Jetté, CA
Chief Financial Officer
Mr. Jetté has been Chief Financial Officer of Warnex since April 2008. From November 2005 to March 2008, he was Warnex's Corporate Controller. From 1999 until joining Warnex, Mr. Jetté was Controller for Pretium Canada Company. From 1997 to 1999, he was Controller for Naya Inc.
Dr. Michael Mancini
President, Warnex Bioanalytical Services
Dr. Mancini has been President of Warnex Bioanalytical Services since 2002. Dr. Mancini was also President of Warnex Analytical Services Inc. from June 2000 to March 2007. From 1996 until joining Warnex, he was Director of Business Development and Scientific Liaison with MDS Pharma Services Inc. and prior to that, he was Head of the Bioanalytical department of LAB-BioResearch. Dr. Mancini holds a Ph.D. in Chemistry from McGill University, where his research focused on the synthesis of a new class of anticancer drugs. He completed two years of postdoctoral work developing synthetic strategies for novel anti-viral agents modeled after AZT before joining the National Research Council’s Biotechnology Research Institute (BRI) as a Research Associate in the Protein Engineering Department. During his tenure at BRI, he developed his interest in mass spectrometry, which led to his career in contract research.
Dr. Yvan Côté
Vice President & General Manager, Warnex Medical Laboratories
Dr. Côté has been Vice President and General Manager, Warnex Medical Laboratories since January 2005. Dr. Côté was also Vice President, Research & Development of Warnex Research Inc. from September 2003 to June 2007. From January 2003 until joining Warnex, he was Director, Clinical Research with ART Advanced Research Technologies Inc. Dr. Côté held different positions with Adaltis Inc. (BioChem ImmunoSystems Inc.), including Director, Clinical Laboratory and Research & Development, from June 1995 to July 2003. He holds a Bachelor's degree in Biotechnology and a Ph.D. in Cellular Biology from Sherbrooke University. Following the completion of his Doctorate degree, Dr. Côté accumulated several prestigious fellowships and conducted two postdoctoral positions at the University of Connecticut Health Centre and Yale University. He is the author of many publications in the medical field and has been guest lecturer for a number of conferences in the diagnostic field. He is also Scientific Advisor for Immucon, a member of the Advisory Council of the AOAC Research Institute, and Associate Professor of the University of Sherbrooke's Biology Department.
Erik Yelle
Vice President, Operations, Warnex Analytical Services Inc.
Mr. Yelle has been Vice President, Operations of Warnex Analytical Services Inc. since March 2007. Mr. Yelle was also Vice President, Sales & Marketing of Warnex Diagnostics Inc. from January 2006 to June 2007. He has over 15 years of experience in sales development and management obtained through his various roles within a multinational leader in the food industry, McCain Foods. His most recent position was Vice-President, Sales and Marketing of Wong Wing Foods Inc., a McCain Foods company, where he was responsible for the national launch of a new line of products, the restructuring of various departments and all aspects of the marketing strategy. In 2003, he was Retail Category Manager and between 1998 and 2002, he was the Quebec Director of Sales for McCain Foods Canada.
